Search Results

Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma.

• Authors : Li, Boyang^1,2 (AUTHOR); Liu, Shihui^1,2 (AUTHOR); Zhou, Xiaowan^1,3 (AUTHOR)

Subjects: *SQUAMOUS cell carcinoma; *IRON chelates; *IMMUNOHISTOCHEMISTRY

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 4, p1524. 18p.

Record details

Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.

• Authors : Yu, Kexin¹ (AUTHOR) ; Zhang, Shibo¹ (AUTHOR); Shen, Jiali¹ (AUTHOR)

Subjects: *SQUAMOUS cell carcinoma; *GENE regulatory networks; *RNA sequencing

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p1362. 18p.

Record details

Connexin 43 Expression as Biomarker of Oral Squamous Cell Carcinoma and Its Association with Human Papillomavirus 16 and 18.

• Authors : Gutierrez-Camacho, Jose Roberto¹ (AUTHOR) ; Avila-Carrasco, Lorena¹ (AUTHOR) ; Garza-Veloz, Idalia¹ (AUTHOR)

Subjects: *HUMAN papillomavirus; *CONNEXIN 43; *HEAD & neck cancer

• Source: International Journal of Molecular Sciences. Feb2025, Vol. 26 Issue 3, p1232. 15p.

Record details

Synergistic anticancer effects of cisplatin and phenolic aglycones of the aerial part of Rumex dentatus L. in tongue squamous cell carcinoma: insights from network pharmacology and biological verification.

• Authors : Ragab, Amany E.¹ (AUTHOR) ; Al-Ashmawy, Ghada M.^2,3 (AUTHOR) ; Afify, Sherin R. El⁴ (AUTHOR)

Subjects: *THERAPEUTIC use of antineoplastic agents; *PHYTOTHERAPY; *SQUAMOUS cell carcinoma

• Source: BMC Complementary Medicine & Therapies. 1/25/2025, Vol. 25 Issue 1, p1-28. 28p.

Record details

Development a glycosylated extracellular vesicle-derived miRNA Signature for early detection of esophageal squamous cell carcinoma.

• Authors : Chen, Jianlin^1,2 (AUTHOR); Zheng, Yue^1,2 (AUTHOR); Wang, Zhen³ (AUTHOR)

• Source: BMC Medicine. 1/23/2025, Vol. 23 Issue 1, p1-15. 15p.

Record details

The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma.

• Authors : Wang, Ruifeng¹ (AUTHOR) ; Guo, Tianhui¹ (AUTHOR) ; Wang, Qi¹ (AUTHOR)

• Source: BMC Cancer. 1/16/2025, Vol. 25 Issue 1, p1-12. 12p.

Record details

Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma.

• Authors : Duan, Xiaofeng^1,2 (AUTHOR) ; Yue, Jie¹ (AUTHOR); Wang, Shangren¹ (AUTHOR)

• Source: BMC Cancer. 1/10/2025, Vol. 25 Issue 1, p1-11. 11p.

Record details

Combining the Albumin-to-fibrinogen ratio and pathologic factors predicts survival in surgically treated patients with esophageal squamous cell carcinoma.

• Authors : Zhang, Xueshun¹ (AUTHOR); Li, Xinyu² (AUTHOR); Xing, Lei¹ (AUTHOR)

• Source: Oncologie (De Gruyter). Jan2025, Vol. 27 Issue 1, p137-147. 11p.

Record details

The roles of G protein-coupled receptor genes and the tumor microenvironment in esophageal squamous cell carcinoma.

• Authors : Shen, Lihong¹ (AUTHOR); Hu, Rongrong^2,3 (AUTHOR); Huang, Guiying^2,3 (AUTHOR)

• Source: Oncologie (De Gruyter). Jan2025, Vol. 27 Issue 1, p127-136. 10p.

Record details

Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy.

• Authors : Lai, Yutian^1,2 (AUTHOR); Dong, Yingxian^1,2 (AUTHOR); Tian, Long^1,2 (AUTHOR)

• Source: World Journal of Surgical Oncology. 1/2/2025, Vol. 23 Issue 1, p1-10. 10p.

Record details